Thalia Therapeutics PLC (THAT)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.55p

Buy

0.60p

arrow-down-0.025p (-4.35%)

Prices updated at 27 Apr 2026, 15:24 BST

Prices minimum 15 mins delay

Prices in GBX

N4 Pharma PLC is a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance. Its vaccines include Nuvac and Nuvec.

FTSE All-Share

-0.49%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	0.60p - 0.55p
	1.00p - 0.35p
	-
	4.79m
	-
	300,000
	7,101,749
	2.71
	1,537,112.97
	3.26
	394.78m
	GB00BYW8QM32
	0.00
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.